ARV/ART

With funding from PEPFAR, the Human Resources for Health in 2030 (HRH2030) has developed, piloted, and field-tested a tool to help health facility staff and district health management teams optimize their health workforce for the roll-out of “Test and Start” utilizing

The efficacy of first-line antiretroviral therapy (ART) continues to improve, according to an analysis of outcomes in 78,000 people in 181 studies, published in AIDS by Professor Andrew Carr of St Vincent's Hospital in Sydney and colleagues.

In recent years, an overwhelming body of clinical evidence has firmly established the HIV Undetectable = Untransmittable (U=U) concept as scientifically sound, say officials from the National Institutes of Health.

In 2016, the Prevention Access Campaign, a health equity initiative with the goal of ending the HIV/AIDS pandemic as well as HIV-related stigma, launched the Undetectable = Untransmittable (U = U) initiative. U = U signifies that individuals with HIV who receive antiretroviral therapy (ART) and h

Multiple partners, migration, and living in an HIV ‘hotspot’ have been identified as key drivers of unsuppressed viral load among young women living with HIV in KwaZulu-Natal, South Africa.

A new report from UNAIDS shows that intensified HIV testing and treatment efforts are reaching more people living with HIV.

For people who may have been exposed to HIV, knowledge is critical to making informed decisions about their future. An HIV test is a serious event with potentially serious outcomes. But no matter the result, the test provides vital information.

South Africa boasts the world’s largest HIV treatment programme but are provinces ready to take the lead?

Ukuba sempilweni lilungelo lethu singabantu. Zininzi izinto esingazenza singabantu kwakunye nabahlali ukuzigcina sisempilweni kangangoko. Oku kuya kuqinisekisa ukuba singakwazi ukuphila impilo ende enolonwabo kwaye sinakekele abo sibathandayo.